Colonize, evade, flourish

References

• Blaser MJ. Helicobacter pylori and gastric diseases. BMJ 1998; 316:1507 - 10; http://dx.doi.org/10.1136/bmj.316.7143.1507; PMID: 9582144
   PubMed Web of Science ®Google Scholar
• Brown LM. Helicobacter pylori: epidemiology and routes of transmission. Epidemiol Rev 2000; 22:283 - 97; http://dx.doi.org/10.1093/oxfordjournals.epirev.a018040; PMID: 11218379
   PubMed Web of Science ®Google Scholar
• Raetz CRH, Whitfield C. Lipopolysaccharide endotoxins. Annu Rev Biochem 2002; 71:635 - 700; http://dx.doi.org/10.1146/annurev.biochem.71.110601.135414; PMID: 12045108
   PubMed Web of Science ®Google Scholar
• Lerouge I, Vanderleyden J. O-antigen structural variation: mechanisms and possible roles in animal/plant-microbe interactions. FEMS Microbiol Rev 2002; 26:17 - 47; http://dx.doi.org/10.1111/j.1574-6976.2002.tb00597.x; PMID: 12007641
   PubMed Web of Science ®Google Scholar
• Moran AP. Relevance of fucosylation and Lewis antigen expression in the bacterial gastroduodenal pathogen Helicobacter pylori.. Carbohydr Res 2008; 343:1952 - 65; http://dx.doi.org/10.1016/j.carres.2007.12.012; PMID: 18279843
   PubMed Web of Science ®Google Scholar
• Berg DE, Hoffman PS, Appelmelk BJ, Kusters JG. The Helicobacter pylori genome sequence: genetic factors for long life in the gastric mucosa. Trends Microbiol 1997; 5:468 - 74; http://dx.doi.org/10.1016/S0966-842X(97)01164-5; PMID: 9447657
   PubMed Web of Science ®Google Scholar
• Hug I, Feldman MF. Analogies and homologies in lipopolysaccharide and glycoprotein biosynthesis in bacteria. [cited 2013 May 7 ] Glycobiology 2011; 21:138 - 51; http://dx.doi.org/10.1093/glycob/cwq148; PMID: 20871101
   PubMed Web of Science ®Google Scholar
• Hug I, Couturier MR, Rooker MM, Taylor DE, Stein M, Feldman MF. Helicobacter pylori lipopolysaccharide is synthesized via a novel pathway with an evolutionary connection to protein N-glycosylation. PLoS Pathog 2010; 6:e1000819; http://dx.doi.org/10.1371/journal.ppat.1000819; PMID: 20333251
   PubMedGoogle Scholar
• Alaimo C, Catrein I, Morf L, Marolda CL, Callewaert N, Valvano MA, et al. Two distinct but interchangeable mechanisms for flipping of lipid-linked oligosaccharides. EMBO J 2006; 25:967 - 76; http://dx.doi.org/10.1038/sj.emboj.7601024; PMID: 16498400
   PubMed Web of Science ®Google Scholar
• El Ghachi M, Derbise A, Bouhss A, Mengin-Lecreulx D. Identification of multiple genes encoding membrane proteins with undecaprenyl pyrophosphate phosphatase (UppP) activity in Escherichia coli.. J Biol Chem 2005; 280:18689 - 95; http://dx.doi.org/10.1074/jbc.M412277200; PMID: 15778224
   PubMed Web of Science ®Google Scholar
• Sperandeo P, Dehò G, Polissi A. The lipopolysaccharide transport system of Gram-negative bacteria. Biochim Biophys Acta 2009; 1791:594 - 602; http://dx.doi.org/10.1016/j.bbalip.2009.01.011; PMID: 19416651
   PubMed Web of Science ®Google Scholar
• Liechti G, Goldberg JB. Outer membrane biogenesis in Escherichia coli, Neisseria meningitidis, and Helicobacter pylori: paradigm deviations in H. pylori.. Front Cell Infect Microbiol 2012; 2:29; http://dx.doi.org/10.3389/fcimb.2012.00029; PMID: 22919621
   PubMed Web of Science ®Google Scholar
• Bos MP, Tommassen J. The LptD chaperone LptE is not directly involved in lipopolysaccharide transport in Neisseria meningitidis.. J Biol Chem 2011; 286:28688 - 96; http://dx.doi.org/10.1074/jbc.M111.239673; PMID: 21705335
   PubMed Web of Science ®Google Scholar
• Raetz CRH, Reynolds CM, Trent MS, Bishop RE. Lipid A modification systems in gram-negative bacteria. Annu Rev Biochem 2007; 76:295 - 329; http://dx.doi.org/10.1146/annurev.biochem.76.010307.145803; PMID: 17362200
   PubMed Web of Science ®Google Scholar
• Muotiala A, Helander IM, Pyhälä L, Kosunen TU, Moran AP. Low biological activity of Helicobacter pylori lipopolysaccharide. Infect Immun 1992; 60:1714 - 6; PMID: 1548097
   PubMed Web of Science ®Google Scholar
• Ogawa T, Suda Y, Kashihara W, Hayashi T, Shimoyama T, Kusumoto S, et al. Immunobiological activities of chemically defined lipid A from Helicobacter pylori LPS in comparison with Porphyromonas gingivalis lipid A and Escherichia coli-type synthetic lipid A (compound 506). Vaccine 1997; 15:1598 - 605; http://dx.doi.org/10.1016/S0264-410X(97)00102-3; PMID: 9364689
   PubMed Web of Science ®Google Scholar
• Ogawa T, Asai Y, Sakai Y, Oikawa M, Fukase K, Suda Y, et al. Endotoxic and immunobiological activities of a chemically synthesized lipid A of Helicobacter pylori strain 206-1. FEMS Immunol Med Microbiol 2003; 36:1 - 7; http://dx.doi.org/10.1016/S0928-8244(03)00093-2; PMID: 12727359
   PubMed Web of Science ®Google Scholar
• Raetz CR. Biochemistry of endotoxins. Annu Rev Biochem 1990; 59:129 - 70; http://dx.doi.org/10.1146/annurev.bi.59.070190.001021; PMID: 1695830
   PubMed Web of Science ®Google Scholar
• Tran AX, Whittimore JD, Wyrick PB, McGrath SC, Cotter RJ, Trent MS. The lipid A 1-phosphatase of Helicobacter pylori is required for resistance to the antimicrobial peptide polymyxin. J Bacteriol 2006; 188:4531 - 41; http://dx.doi.org/10.1128/JB.00146-06; PMID: 16740959
   PubMed Web of Science ®Google Scholar
• Stead CM, Beasley A, Cotter RJ, Trent MS. Deciphering the unusual acylation pattern of Helicobacter pylori lipid A. J Bacteriol 2008; 190:7012 - 21; http://dx.doi.org/10.1128/JB.00667-08; PMID: 18757539
   PubMed Web of Science ®Google Scholar
• Tran AX, Karbarz MJ, Wang X, Raetz CRH, McGrath SC, Cotter RJ, et al. Periplasmic cleavage and modification of the 1-phosphate group of Helicobacter pylori lipid A. J Biol Chem 2004; 279:55780 - 91; http://dx.doi.org/10.1074/jbc.M406480200; PMID: 15489235
   PubMed Web of Science ®Google Scholar
• Stead CM, Zhao J, Raetz CRH, Trent MS. Removal of the outer Kdo from Helicobacter pylori lipopolysaccharide and its impact on the bacterial surface. Mol Microbiol 2010; 78:837 - 52; http://dx.doi.org/10.1111/j.1365-2958.2010.07304.x; PMID: 20659292
   PubMed Web of Science ®Google Scholar
• Cullen TW, Giles DK, Wolf LN, Ecobichon C, Boneca IG, Trent MS. Helicobacter pylori versus the host: remodeling of the bacterial outer membrane is required for survival in the gastric mucosa. PLoS Pathog 2011; 7:e1002454; http://dx.doi.org/10.1371/journal.ppat.1002454; PMID: 22216004
   PubMedGoogle Scholar
• Kawasaki K, Ernst RK, Miller SI. 3-O-deacylation of lipid A by PagL, a PhoP/PhoQ-regulated deacylase of Salmonella typhimurium, modulates signaling through Toll-like receptor 4. J Biol Chem 2004; 279:20044 - 8; http://dx.doi.org/10.1074/jbc.M401275200; PMID: 15014080
   PubMed Web of Science ®Google Scholar
• Coats SR, Pham T-TT, Bainbridge BW, Reife RA, Darveau RP. MD-2 mediates the ability of tetra-acylated and penta-acylated lipopolysaccharides to antagonize Escherichia coli lipopolysaccharide at the TLR4 signaling complex. J Immunol 2005; 175:4490 - 8; PMID: 16177092
   PubMed Web of Science ®Google Scholar
• Teghanemt A, Zhang D, Levis EN, Weiss JP, Gioannini TL. Molecular basis of reduced potency of underacylated endotoxins. J Immunol 2005; 175:4669 - 76; PMID: 16177114
   PubMed Web of Science ®Google Scholar
• Cullen TW, Trent MS. A link between the assembly of flagella and lipooligosaccharide of the Gram-negative bacterium Campylobacter jejuni.. Proc Natl Acad Sci U S A 2010; 107:5160 - 5; http://dx.doi.org/10.1073/pnas.0913451107; PMID: 20194750
   PubMed Web of Science ®Google Scholar
• Scott NE, Nothaft H, Edwards AVG, Labbate M, Djordjevic SP, Larsen MR, et al. Modification of the Campylobacter jejuni N-linked glycan by EptC protein-mediated addition of phosphoethanolamine. J Biol Chem 2012; 287:29384 - 96; http://dx.doi.org/10.1074/jbc.M112.380212; PMID: 22761430
   PubMed Web of Science ®Google Scholar
• Cullen TW, O’Brien JP, Hendrixson DR, Giles DK, Hobb RI, Thompson SA, et al. EptC of Campylobacter jejuni mediates phenotypes involved in host interactions and virulence. Infect Immun 2013; 81:430 - 40; http://dx.doi.org/10.1128/IAI.01046-12; PMID: 23184526
   PubMed Web of Science ®Google Scholar
• Simoons-Smit IM, Appelmelk BJ, Verboom T, Negrini R, Penner JL, Aspinall GO, et al. Typing of Helicobacter pylori with monoclonal antibodies against Lewis antigens in lipopolysaccharide. J Clin Microbiol 1996; 34:2196 - 200; PMID: 8862584
   PubMedGoogle Scholar
• Heneghan MA, McCarthy CF, Moran AP. Relationship of blood group determinants on Helicobacter pylori lipopolysaccharide with host lewis phenotype and inflammatory response. Infect Immun 2000; 68:937 - 41; http://dx.doi.org/10.1128/IAI.68.2.937-941.2000; PMID: 10639467
   PubMed Web of Science ®Google Scholar
• Kocharova NA, Knirel YA, Widmalm G, Jansson PE, Moran AP. Structure of an atypical O-antigen polysaccharide of Helicobacter pylori containing a novel monosaccharide 3-C-methyl-D-mannose. Biochemistry 2000; 39:4755 - 60; http://dx.doi.org/10.1021/bi992635k; PMID: 10769132
   PubMed Web of Science ®Google Scholar
• Logan SM, Conlan JW, Monteiro MA, Wakarchuk WW, Altman E. Functional genomics of Helicobacter pylori: identification of a beta-1,4 galactosyltransferase and generation of mutants with altered lipopolysaccharide. Mol Microbiol 2000; 35:1156 - 67; http://dx.doi.org/10.1046/j.1365-2958.2000.01784.x; PMID: 10712696
   PubMed Web of Science ®Google Scholar
• Pohl MA, Romero-Gallo J, Guruge JL, Tse DB, Gordon JI, Blaser MJ. Host-dependent Lewis (Le) antigen expression in Helicobacter pylori cells recovered from Leb-transgenic mice. J Exp Med 2009; 206:3061 - 72; http://dx.doi.org/10.1084/jem.20090683; PMID: 20008521
   PubMed Web of Science ®Google Scholar
• Logan SM, Altman E, Mykytczuk O, Brisson J-R, Chandan V, Schur MJ, et al. Novel biosynthetic functions of lipopolysaccharide rfaJ homologs from Helicobacter pylori.. Glycobiology 2005; 15:721 - 33; http://dx.doi.org/10.1093/glycob/cwi057; PMID: 15814825
   PubMed Web of Science ®Google Scholar
• Aspinall GO, Monteiro MA, Moran AP, Pang H, Penner JL, Shaver RT. Lipopolysaccharides from Helicobacter pylori.. Prog Clin Biol Res 1995; 392:93 - 101; PMID: 8524968
   PubMedGoogle Scholar
• Aspinall GO, Monteiro MA, Pang H, Walsh EJ, Moran AP. Lipopolysaccharide of the Helicobacter pylori type strain NCTC 11637 (ATCC 43504): structure of the O antigen chain and core oligosaccharide regions. Biochemistry 1996; 35:2489 - 97; http://dx.doi.org/10.1021/bi951852s; PMID: 8652593
   PubMed Web of Science ®Google Scholar
• Nilsson C, Skoglund A, Moran AP, Annuk H, Engstrand L, Normark S. An enzymatic ruler modulates Lewis antigen glycosylation of Helicobacter pylori LPS during persistent infection. Proc Natl Acad Sci U S A 2006; 103:2863 - 8; http://dx.doi.org/10.1073/pnas.0511119103; PMID: 16477004
   PubMed Web of Science ®Google Scholar
• Appelmelk BJ, Monteiro MA, Martin SL, Moran AP, Vandenbroucke-Grauls CM. Why Helicobacter pylori has Lewis antigens. Trends Microbiol 2000; 8:565 - 70; http://dx.doi.org/10.1016/S0966-842X(00)01875-8; PMID: 11115753
   PubMed Web of Science ®Google Scholar
• Alm RA, Ling LS, Moir DT, King BL, Brown ED, Doig PC, et al. Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori.. Nature 1999; 397:176 - 80; http://dx.doi.org/10.1038/16495; PMID: 9923682
   PubMed Web of Science ®Google Scholar
• Wang G, Ge Z, Rasko DA, Taylor DE. Lewis antigens in Helicobacter pylori: biosynthesis and phase variation. Mol Microbiol 2000; 36:1187 - 96; http://dx.doi.org/10.1046/j.1365-2958.2000.01934.x; PMID: 10931272
   PubMed Web of Science ®Google Scholar
• Appelmelk BJ, Negrini R, Moran AP, Kuipers EJ. Molecular mimicry between Helicobacter pylori and the host. Trends Microbiol 1997; 5:70 - 3; http://dx.doi.org/10.1016/S0966-842X(96)10084-6; PMID: 9108933
   PubMed Web of Science ®Google Scholar
• Pohl MA, Kienesberger S, Blaser MJ. Novel functions for glycosyltransferases Jhp0562 and GalT in Lewis antigen synthesis and variation in Helicobacter pylori.. Infect Immun 2012; 80:1593 - 605; http://dx.doi.org/10.1128/IAI.00032-12; PMID: 22290141
   PubMed Web of Science ®Google Scholar
• Nilsson C, Skoglund A, Moran AP, Annuk H, Engstrand L, Normark S. Lipopolysaccharide diversity evolving in Helicobacter pylori communities through genetic modifications in fucosyltransferases. PLoS One 2008; 3:e3811; http://dx.doi.org/10.1371/journal.pone.0003811; PMID: 19043574
   PubMed Web of Science ®Google Scholar
• Monteiro MA, St Michael F, Rasko DA, Taylor DE, Conlan JW, Chan KH, et al. Helicobacter pylori from asymptomatic hosts expressing heptoglycan but lacking Lewis O-chains: Lewis blood-group O-chains may play a role in Helicobacter pylori induced pathology. Biochem Cell Biol 2001; 79:449 - 59; PMID: 11527214
   PubMed Web of Science ®Google Scholar
• Edwards NJ, Monteiro MA, Faller G, Walsh EJ, Moran AP, Roberts IS, et al. Lewis X structures in the O antigen side-chain promote adhesion of Helicobacter pylori to the gastric epithelium. Mol Microbiol 2000; 35:1530 - 9; http://dx.doi.org/10.1046/j.1365-2958.2000.01823.x; PMID: 10760152
   PubMed Web of Science ®Google Scholar
• Fowler M, Thomas RJ, Atherton J, Roberts IS, High NJ. Galectin-3 binds to Helicobacter pylori O-antigen: it is upregulated and rapidly secreted by gastric epithelial cells in response to H. pylori adhesion. Cell Microbiol 2006; 8:44 - 54; http://dx.doi.org/10.1111/j.1462-5822.2005.00599.x; PMID: 16367865
   PubMed Web of Science ®Google Scholar
• Bergman MP, Engering A, Smits HH, van Vliet SJ, van Bodegraven AA, Wirth H-P, et al. Helicobacter pylori modulates the T helper cell 1/T helper cell 2 balance through phase-variable interaction between lipopolysaccharide and DC-SIGN. J Exp Med 2004; 200:979 - 90; http://dx.doi.org/10.1084/jem.20041061; PMID: 15492123
   PubMed Web of Science ®Google Scholar
• Ghuysen J-M, Hakenbeck R. Bacterial Cell Wall. Elsevier; 1994.
   Google Scholar
• Höltje JV. Growth of the stress-bearing and shape-maintaining murein sacculus of Escherichia coli.. Microbiol Mol Biol Rev 1998; 62:181 - 203; PMID: 9529891
   PubMed Web of Science ®Google Scholar
• Takebe I. Extent of cross linkage in the murein sacculus of Escherichia coli B cell wall. Biochim Biophys Acta 1965; 101:124 - 6; http://dx.doi.org/10.1016/0926-6534(65)90038-2; PMID: 14329278
   PubMed Web of Science ®Google Scholar
• Costa K, Bacher G, Allmaier G, Dominguez-Bello MG, Engstrand L, Falk P, et al. The morphological transition of Helicobacter pylori cells from spiral to coccoid is preceded by a substantial modification of the cell wall. J Bacteriol 1999; 181:3710 - 5; PMID: 10368145
   PubMed Web of Science ®Google Scholar
• Harz H, Burgdorf K, Höltje JV. Isolation and separation of the glycan strands from murein of Escherichia coli by reversed-phase high-performance liquid chromatography. Anal Biochem 1990; 190:120 - 8; http://dx.doi.org/10.1016/0003-2697(90)90144-X; PMID: 2285138
   PubMed Web of Science ®Google Scholar
• Sycuro LK, Pincus Z, Gutierrez KD, Biboy J, Stern CA, Vollmer W, et al. Peptidoglycan crosslinking relaxation promotes Helicobacter pylori’s helical shape and stomach colonization. Cell 2010; 141:822 - 33; http://dx.doi.org/10.1016/j.cell.2010.03.046; PMID: 20510929
   PubMed Web of Science ®Google Scholar
• Bonis M, Ecobichon C, Guadagnini S, Prévost M-C, Boneca IGA. A M23B family metallopeptidase of Helicobacter pylori required for cell shape, pole formation and virulence. Mol Microbiol 2010; 78:809 - 19; http://dx.doi.org/10.1111/j.1365-2958.2010.07383.x; PMID: 20815828
   PubMed Web of Science ®Google Scholar
• Sycuro LK, Wyckoff TJ, Biboy J, Born P, Pincus Z, Vollmer W, et al. Multiple peptidoglycan modification networks modulate Helicobacter pylori’s cell shape, motility, and colonization potential. PLoS Pathog 2012; 8:e1002603; http://dx.doi.org/10.1371/journal.ppat.1002603; PMID: 22457625
   PubMedGoogle Scholar
• Frirdich E, Biboy J, Adams C, Lee J, Ellermeier J, Gielda LD, et al. Peptidoglycan-modifying enzyme Pgp1 is required for helical cell shape and pathogenicity traits in Campylobacter jejuni.. PLoS Pathog 2012; 8:e1002602; http://dx.doi.org/10.1371/journal.ppat.1002602; PMID: 22457624
   PubMedGoogle Scholar
• Chaput C, Ecobichon C, Cayet N, Girardin SE, Werts C, Guadagnini S, et al. Role of AmiA in the morphological transition of Helicobacter pylori and in immune escape. PLoS Pathog 2006; 2:e97; http://dx.doi.org/10.1371/journal.ppat.0020097; PMID: 17002496
   PubMedGoogle Scholar
• van Heijenoort J. Peptidoglycan hydrolases of Escherichia coli.. [cited 2013 May 22 ] Microbiol Mol Biol Rev 2011; 75:636 - 63; http://dx.doi.org/10.1128/MMBR.00022-11; PMID: 22126997
   PubMed Web of Science ®Google Scholar
• Scheurwater E, Reid CW, Clarke AJ. Lytic transglycosylases: bacterial space-making autolysins. Int J Biochem Cell Biol 2008; 40:586 - 91; http://dx.doi.org/10.1016/j.biocel.2007.03.018; PMID: 17468031
   PubMed Web of Science ®Google Scholar
• Helicobacter pylori: physiology and genetics. Washington, DC: ASM Press; 2001.
   Google Scholar
• Viala J, Chaput C, Boneca IG, Cardona A, Girardin SE, Moran AP, et al. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol 2004; 5:1166 - 74; http://dx.doi.org/10.1038/ni1131; PMID: 15489856
   PubMed Web of Science ®Google Scholar
• Wang G, Olczak A, Forsberg LS, Maier RJ. Oxidative stress-induced peptidoglycan deacetylase in Helicobacter pylori.. J Biol Chem 2009; 284:6790 - 800; http://dx.doi.org/10.1074/jbc.M808071200; PMID: 19147492
   PubMed Web of Science ®Google Scholar
• Wang G, Maier SE, Lo LF, Maier G, Dosi S, Maier RJ. Peptidoglycan deacetylation in Helicobacter pylori contributes to bacterial survival by mitigating host immune responses. Infect Immun 2010; 78:4660 - 6; http://dx.doi.org/10.1128/IAI.00307-10; PMID: 20805339
   PubMed Web of Science ®Google Scholar
• Wang G, Lo LF, Forsberg LS, Maier RJ. Helicobacter pylori peptidoglycan modifications confer lysozyme resistance and contribute to survival in the host. MBio 2012; 3:e00409 - 12; http://dx.doi.org/10.1128/mBio.00409-12; PMID: 23221800
   PubMedGoogle Scholar
• Vollmer W. Structural variation in the glycan strands of bacterial peptidoglycan. FEMS Microbiol Rev 2008; 32:287 - 306; http://dx.doi.org/10.1111/j.1574-6976.2007.00088.x; PMID: 18070068
   PubMed Web of Science ®Google Scholar
• Schirm M, Soo EC, Aubry AJ, Austin J, Thibault P, Logan SM. Structural, genetic and functional characterization of the flagellin glycosylation process in Helicobacter pylori.. Mol Microbiol 2003; 48:1579 - 92; http://dx.doi.org/10.1046/j.1365-2958.2003.03527.x; PMID: 12791140
   PubMed Web of Science ®Google Scholar
• Thibault P, Logan SM, Kelly JF, Brisson JR, Ewing CP, Trust TJ, et al. Identification of the carbohydrate moieties and glycosylation motifs in Campylobacter jejuni flagellin. J Biol Chem 2001; 276:34862 - 70; http://dx.doi.org/10.1074/jbc.M104529200; PMID: 11461915
   PubMed Web of Science ®Google Scholar
• McNally DJ, Hui JPM, Aubry AJ, Mui KKK, Guerry P, Brisson J-R, et al. Functional characterization of the flagellar glycosylation locus in Campylobacter jejuni 81-176 using a focused metabolomics approach. J Biol Chem 2006; 281:18489 - 98; http://dx.doi.org/10.1074/jbc.M603777200; PMID: 16684771
   PubMed Web of Science ®Google Scholar
• Gilbreath JJ, Cody WL, Merrell DS, Hendrixson DR. Change is good: variations in common biological mechanisms in the epsilonproteobacterial genera Campylobacter and Helicobacter. Microbiol Mol Biol Rev 2011; 75:84 - 132; http://dx.doi.org/10.1128/MMBR.00035-10; PMID: 21372321
   PubMed Web of Science ®Google Scholar
• Asakura H, Churin Y, Bauer B, Boettcher JP, Bartfeld S, Hashii N, et al. Helicobacter pylori HP0518 affects flagellin glycosylation to alter bacterial motility. Mol Microbiol 2010; 78:1130 - 44; http://dx.doi.org/10.1111/j.1365-2958.2010.07393.x; PMID: 21091500
   PubMed Web of Science ®Google Scholar
• Höpf PS, Ford RS, Zebian N, Merkx-Jacques A, Vijayakumar S, Ratnayake D, et al. Protein glycosylation in Helicobacter pylori: beyond the flagellins?. PLoS One 2011; 6:e25722; http://dx.doi.org/10.1371/journal.pone.0025722; PMID: 21984942
   PubMedGoogle Scholar
• Nothaft H, Liu X, McNally DJ, Li J, Szymanski CM. Study of free oligosaccharides derived from the bacterial N-glycosylation pathway. [cited 2013 Jun 5 ] Proc Natl Acad Sci U S A 2009; 106:15019 - 24; http://dx.doi.org/10.1073/pnas.0903078106; PMID: 19706478
   PubMed Web of Science ®Google Scholar
• Szymanski CM, Yao R, Ewing CP, Trust TJ, Guerry P. Evidence for a system of general protein glycosylation in Campylobacter jejuni.. Mol Microbiol 1999; 32:1022 - 30; http://dx.doi.org/10.1046/j.1365-2958.1999.01415.x; PMID: 10361304
   PubMed Web of Science ®Google Scholar
• Hug I, Zheng B, Reiz B, Whittal RM, Fentabil MA, Klassen JS, et al. Exploiting bacterial glycosylation machineries for the synthesis of a Lewis antigen-containing glycoprotein. J Biol Chem 2011; 286:37887 - 94; http://dx.doi.org/10.1074/jbc.M111.287755; PMID: 21878645
   PubMed Web of Science ®Google Scholar
• Altman E, Chandan V, Harrison BA, Veloso-Pita R, Li J, KuoLee R, et al, Regional Helicobacter pylori Study Group. Design and immunological properties of Helicobacter pylori glycoconjugates based on a truncated lipopolysaccharide lacking Lewis antigen and comprising an α-1,6-glucan chain. Vaccine 2012; 30:7332 - 41; http://dx.doi.org/10.1016/j.vaccine.2012.04.035; PMID: 22534169
   PubMed Web of Science ®Google Scholar
• Ansorg R, Müller KD, von Recklinghausen G, Nalik HP. Cholesterol binding of Helicobacter pylori.. Zentralbl Bakteriol 1992; 276:323 - 9; http://dx.doi.org/10.1016/S0934-8840(11)80538-4; PMID: 1576402
   PubMedGoogle Scholar
• Haque M, Hirai Y, Yokota K, Oguma K. Lipid profiles of Helicobacter pylori and Helicobacter mustelae grown in serum-supplemented and serum-free media. Acta Med Okayama 1995; 49:205 - 11; PMID: 7502681
   PubMed Web of Science ®Google Scholar
• Testerman TL, McGee DJ, Mobley HL. Helicobacter pylori growth and urease detection in the chemically defined medium Ham’s F-12 nutrient mixture. J Clin Microbiol 2001; 39:3842 - 50; http://dx.doi.org/10.1128/JCM.39.11.3842-3850.2001; PMID: 11682496
   PubMed Web of Science ®Google Scholar
• Wunder C, Churin Y, Winau F, Warnecke D, Vieth M, Lindner B, et al. Cholesterol glucosylation promotes immune evasion by Helicobacter pylori.. Nat Med 2006; 12:1030 - 8; http://dx.doi.org/10.1038/nm1480; PMID: 16951684
   PubMed Web of Science ®Google Scholar
• McGee DJ, George AE, Trainor EA, Horton KE, Hildebrandt E, Testerman TL. Cholesterol enhances Helicobacter pylori resistance to antibiotics and LL-37. Antimicrob Agents Chemother 2011; 55:2897 - 904; http://dx.doi.org/10.1128/AAC.00016-11; PMID: 21464244
   PubMed Web of Science ®Google Scholar
• Shimomura H, Hosoda K, Hayashi S, Yokota K, Oguma K, Hirai Y. Steroids mediate resistance to the bactericidal effect of phosphatidylcholines against Helicobacter pylori.. FEMS Microbiol Lett 2009; 301:84 - 94; http://dx.doi.org/10.1111/j.1574-6968.2009.01807.x; PMID: 19843309
   PubMed Web of Science ®Google Scholar
• Shimomura H, Hosoda K, McGee DJ, Hayashi S, Yokota K, Hirai Y. Detoxification of 7-dehydrocholesterol fatal to Helicobacter pylori is a novel role of cholesterol glucosylation. J Bacteriol 2013; 195:359 - 67; http://dx.doi.org/10.1128/JB.01495-12; PMID: 23144252
   PubMed Web of Science ®Google Scholar
• Beigier-Bompadre M, Moos V, Belogolova E, Allers K, Schneider T, Churin Y, et al. Modulation of the CD4+ T-cell response by Helicobacter pylori depends on known virulence factors and bacterial cholesterol and cholesterol α-glucoside content. J Infect Dis 2011; 204:1339 - 48; http://dx.doi.org/10.1093/infdis/jir547; PMID: 21921201
   PubMed Web of Science ®Google Scholar
• Wang H-J, Cheng W-C, Cheng H-H, Lai C-H, Wang W-C. Helicobacter pylori cholesteryl glucosides interfere with host membrane phase and affect type IV secretion system function during infection in AGS cells. Mol Microbiol 2012; 83:67 - 84; http://dx.doi.org/10.1111/j.1365-2958.2011.07910.x; PMID: 22053852
   PubMed Web of Science ®Google Scholar
• Lai C-H, Chang Y-C, Du S-Y, Wang H-J, Kuo C-H, Fang S-H, et al. Cholesterol depletion reduces Helicobacter pylori CagA translocation and CagA-induced responses in AGS cells. Infect Immun 2008; 76:3293 - 303; http://dx.doi.org/10.1128/IAI.00365-08; PMID: 18443091
   PubMed Web of Science ®Google Scholar
• Kwok T, Zabler D, Urman S, Rohde M, Hartig R, Wessler S, et al. Helicobacter exploits integrin for type IV secretion and kinase activation. Nature 2007; 449:862 - 6; http://dx.doi.org/10.1038/nature06187; PMID: 17943123
   PubMed Web of Science ®Google Scholar
• Hutton ML, Kaparakis-Liaskos M, Turner L, Cardona A, Kwok T, Ferrero RL. Helicobacter pylori exploits cholesterol-rich microdomains for induction of NF-kappaB-dependent responses and peptidoglycan delivery in epithelial cells. Infect Immun 2010; 78:4523 - 31; http://dx.doi.org/10.1128/IAI.00439-10; PMID: 20713621
   PubMed Web of Science ®Google Scholar